Generic Drugs Generic Pharmaceutical Regulation 
The Pharma Data
MARCH 15, 2022
Agency Supports Development of Complex Generic Drug-Device Combination Product to Improve Competition and Access to More Affordable Medicines. This complex generic drug-device combination product, which is a metered-dose inhaler, should not be used to treat acute asthma attacks. Today, the U.S.
XTalks
AUGUST 2, 2023
In September 2022, Roche acquired Good Therapeutics for an upfront payment of $250 million, and has access to their PD-1-regulated IL-2 program. The company also continued the implementation of some global restructuring plans started in previous years, as well as initiating a portfolio prioritization program for their Pharmaceutical division.
Expert insights. Personalized for you.
52 
Let's personalize your content